0000899243-21-016869.txt : 20210423 0000899243-21-016869.hdr.sgml : 20210423 20210423164548 ACCESSION NUMBER: 0000899243-21-016869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210421 FILED AS OF DATE: 20210423 DATE AS OF CHANGE: 20210423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Evans John M. CENTRAL INDEX KEY: 0001786304 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39208 FILM NUMBER: 21850439 MAIL ADDRESS: STREET 1: C/O BEAM THERAPEUTICS INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Beam Therapeutics Inc. CENTRAL INDEX KEY: 0001745999 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-327-8775 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-21 0 0001745999 Beam Therapeutics Inc. BEAM 0001786304 Evans John M. C/O BEAM THERAPEUTICS INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 1 0 0 CEO Common Stock 2021-04-21 4 S 0 1463 67.90 D 1038966 D Common Stock 2021-04-21 4 S 0 5079 69.02 D 1033887 D Common Stock 2021-04-21 4 S 0 5595 70.23 D 1028292 D Common Stock 2021-04-21 4 S 0 9869 71.38 D 1018423 D Common Stock 2021-04-21 4 S 0 2994 71.79 D 1015429 D Common Stock 2021-04-23 4 M 0 6000 1.03 A 1021429 D Common Stock 223000 I By John M. Evans, III 2018 Irrevocable Trust Stock Option (Right to Buy) 1.03 2021-04-23 4 M 0 6000 0.00 D 2028-07-13 Common Stock 6000 396345 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. These shares were sold in multiple transactions ranging from $67.67 to $68.00 inclusive. These shares were sold in multiple transactions ranging from $68.67 to $69.55 inclusive. These shares were sold in multiple transactions ranging from $69.68 to $70.68 inclusive. These shares were sold in multiple transactions ranging from $70.68 to $71.66 inclusive. These shares were sold in multiple transactions ranging from $71.68 to $71.92 inclusive. The option vests as to 25% on the first anniversary of the of the vesting commencement date, January 8, 2018, and at a rate of 2.78% each month thereafter until the option is fully vested. By: /s/ Christine Bellon, Attorney-in-fact 2021-04-23